SWP
GHDX

Stratos Wealth Partners’s Genomic Health, Inc. GHDX Stock Holding History

Stratos Wealth Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30
Closed -$2K – 2896
2018
Q3 		$2K Buy
+30
New +$1.75K ﹤0.01% 2782
2018
Q2 		– Sell
-30
Closed -$1K – 2978
2018
Q1 		$1K Hold
30
– – ﹤0.01% 3082
2017
Q4 		$1K Buy
+30
New +$957 ﹤0.01% 2776

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stratos Wealth Partners's GHDX Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 30 shares — an estimated $2K sold.

Stratos Wealth Partners first reported a position in GHDX in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 30 Genomic Health, Inc. shares in Q4 2018, an estimated $2K.
  • Stratos Wealth Partners first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Genomic Health, Inc. position peaked at $2K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.